The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

New hiv-meds, close to cure?
Sep 10, 2001

Hi Brian, John, Keith. What are fusion-inhibitors, zincvingers-inhibitors and integrase-inhibitors? At a Dutch site I read those hiv-meds will come and will be a great step forwards to cure hiv-infection. How far or how close are scientists to solve the problem of hiv in anatomical and cellular reservoirs? Thank you for an answer.

Response from Dr. Boyle

The medication classes you mention are in varying stages of development. The fusion inhibitors, which include T-20 and T-1249, block viral entry into the cell by interfering with GP41-related fusion. T-20 is in phase III trials, T-1249 in Phase I. Zinc fingers (which target the HIV nucleocapsid protein zinc fingers and have been around a long time without going anywhere) and integrase inhibitors (which block the integrase enzyme) are in early stages of development. T-20 and T-1249 appear to be an important advance in HIV therapy, especially since they are an entirely new class, but it is too early to comment on the potential of zinc fingers or integrase inhibitors.

Stiffnes in legs
Dizzy & Light headed

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint